Stephanie Berg1, Sucha Nand2. 1. Loyola University Medical Center, Maywood, IL, USA. STEPHANIE.BERG@lumc.edu. 2. Loyola University Medical Center, Maywood, IL, USA.
Abstract
PURPOSE OF REVIEW: Acute and chronic leukemias are heterogeneous diseases and can affect any part of the body upon initial discovery. Understanding the sequela of systemic involvement is key for proper diagnosis and treatment. RECENT FINDINGS: Over the decades, new research has emerged regarding neurological complications of the myeloid or lymphoid leukemias. Central nervous system involvement usually confers a poor prognosis and requires emergent treatment. Standard of care still involves systemic therapy, intrathecal administration of chemotherapeutic agents, and cranial radiation. Treatment-related side effects can occur and need to be recognized by any practitioner involved with patient care. It is imperative to understand neurologic complications from leukemia to prevent delays and initiate necessary treatment to maintain neurologic and cognitive function.
PURPOSE OF REVIEW: Acute and chronic leukemias are heterogeneous diseases and can affect any part of the body upon initial discovery. Understanding the sequela of systemic involvement is key for proper diagnosis and treatment. RECENT FINDINGS: Over the decades, new research has emerged regarding neurological complications of the myeloid or lymphoid leukemias. Central nervous system involvement usually confers a poor prognosis and requires emergent treatment. Standard of care still involves systemic therapy, intrathecal administration of chemotherapeutic agents, and cranial radiation. Treatment-related side effects can occur and need to be recognized by any practitioner involved with patient care. It is imperative to understand neurologic complications from leukemia to prevent delays and initiate necessary treatment to maintain neurologic and cognitive function.
Authors: H M Kantarjian; S O'Brien; T L Smith; J Cortes; F J Giles; M Beran; S Pierce; Y Huh; M Andreeff; C Koller; C S Ha; M J Keating; S Murphy; E J Freireich Journal: J Clin Oncol Date: 2000-02 Impact factor: 44.544
Authors: Rachael F Grace; Suzanne E Dahlberg; Donna Neuberg; Stephen E Sallan; Jean M Connors; Ellis J Neufeld; Daniel J Deangelo; Lewis B Silverman Journal: Br J Haematol Date: 2011-01-07 Impact factor: 6.998
Authors: E Morra; M Lazzarino; E Brusamolino; G Pagnucco; C Castagnola; P Bernasconi; E Orlandi; A Corso; A Santagostino; C Bernasconi Journal: Cancer Date: 1993-07-15 Impact factor: 6.860
Authors: Susanna Ranta; Ruta Tuckuviene; Anne Mäkipernaa; Birgitte K Albertsen; Tony Frisk; Ulf Tedgård; Ólafur G Jónsson; Kaie Pruunsild; Nadine Gretenkort Andersson; Maria Winther Gunnes; Sonata Saulyte Trakymiene; Thomas Frandsen; Mats Heyman; Ellen Ruud; Jon Helgestad Journal: Br J Haematol Date: 2014-10-07 Impact factor: 6.998